LDL Cholesterol: Levels, Ranges, and Risks

LDL cholesterol is the form of cholesterol that doctors watch most closely when assessing heart health, and it is often called “bad cholesterol” because high levels are linked to plaque buildup in the arteries. A simple blood test measures it as part of a routine lipid panel, and the result is usually reported in milligrams per deciliter (mg/dL). This guide explains what LDL cholesterol is, how it is calculated, what counts as a healthy range, and what tends to push it higher, along with a look at how recent research is refining the way clinicians use this marker alongside newer tools like ApoB testing.

What LDL cholesterol is and why it is called “bad”

Cholesterol itself is not harmful. It is a waxy, fat-like substance that every cell in the body needs to build membranes, produce hormones, and make vitamin D. Because cholesterol does not dissolve in blood, it travels through the bloodstream packaged inside particles called lipoproteins. Low-density lipoprotein, or LDL, is one of these carriers, and it is responsible for delivering cholesterol from the liver to the rest of the body.

LDL earns its “bad” reputation because when there is too much of it circulating, the excess cholesterol can settle into the walls of arteries. Over years, this buildup forms plaque that narrows and stiffens blood vessels, a process called atherosclerosis. That narrowing is what eventually raises the risk of heart attack and stroke, which is why lowering LDL cholesterol has become a central goal of cardiovascular prevention. High-density lipoprotein, by contrast, helps carry excess cholesterol back to the liver for removal, which is why it is nicknamed “good cholesterol.”

Normal, borderline, and high LDL cholesterol levels

LDL cholesterol targets are not one-size-fits-all. Doctors interpret a result in the context of a person’s overall cardiovascular risk, including blood pressure, smoking status, diabetes, family history, and whether someone already has known cardiovascular disease. The table below reflects the general categories used in most US clinical guidance for adults without additional risk factors.

These general categories shift for people who already have cardiovascular disease or several risk factors, since a stricter target reduces the chance of a repeat event. A 2026 update to the national dyslipidemia guideline, discussed further below, now recommends an LDL cholesterol goal under 55 mg/dL for adults at very high cardiovascular risk who are receiving treatment after a prior event, and a goal under 70 mg/dL for many people with established disease or strong risk factors, even without a prior event. Anyone reviewing a lab report alongside these categories should still bring questions to a clinician, since personal risk factors change what counts as an appropriate target.

How LDL cholesterol is measured and calculated

A standard lipid panel reports total cholesterol, HDL cholesterol, and triglycerides directly from the blood sample. LDL cholesterol, however, has traditionally been estimated rather than measured directly, using a formula that combines the other three values. The original method, called the Friedewald equation, works reasonably well when triglycerides are close to normal, but it becomes less accurate as triglycerides climb or when LDL cholesterol itself is very low.

To address that gap, many laboratories have shifted to newer calculation methods, including the Martin-Hopkins and Sampson equations, which adjust for the relationship between triglycerides and other lipid particles more precisely. Some labs also offer direct LDL measurement, which skips the calculation altogether and measures LDL particles chemically. Direct measurement or one of these refined equations is generally recommended when triglycerides are elevated, since that is exactly the situation where the older formula loses accuracy. A person reviewing a lipid panel does not need to know which formula a lab used, but understanding that the number can shift slightly depending on the method explains why LDL cholesterol results are sometimes rechecked with a fasting sample or a different calculation approach.

What raises LDL cholesterol

LDL cholesterol levels reflect a mix of genetics, diet, and lifestyle factors, and for most people it is a combination rather than a single cause. Common contributors include the following.

• A diet high in saturated fat and trans fat, found in fried foods, fatty cuts of meat, and many packaged baked goods
• Being overweight or carrying excess weight around the abdomen
• Lack of regular physical activity
• Smoking, which can also lower protective HDL cholesterol
• Certain health conditions, including type 2 diabetes, hypothyroidism, and chronic kidney disease
• Genetic factors, including familial hypercholesterolemia, an inherited condition that causes very high LDL cholesterol from a young age
• Some medications, such as certain steroids and immunosuppressants

Age also plays a role, since LDL cholesterol tends to rise gradually through midlife for many people before leveling off or declining somewhat in older age. This is one reason clinicians often recommend a baseline pannello lipidico in early adulthood, with repeat testing every four to six years for people at average risk, and more frequently for those with risk factors or an abnormal result.

LDL versus HDL, total cholesterol, and ApoB

A single LDL cholesterol number tells only part of the story, which is why it is almost always interpreted alongside other lipid markers. colesterolo HDL works in the opposite direction from LDL, helping clear excess cholesterol rather than deliver it, so a low HDL level can compound the risk from a high LDL level. Colesterolo totale simply adds up LDL, HDL, and a portion of triglycerides, so it can miss important detail when LDL and HDL move in different directions. Comparing LDL against total or HDL cholesterol is sometimes summarized using a rapporto colesterolo, which some clinicians use as an additional way to frame risk.

Apolipoprotein B, or ApoB, has emerged as a complementary marker that some clinicians now request alongside or instead of LDL cholesterol. Every LDL particle, along with other artery-clogging particles like VLDL remnants, carries exactly one ApoB molecule, so an ApoB test counts the actual number of these particles rather than estimating the cholesterol they carry. This distinction matters most for people with elevated trigliceridi, diabetes, or obesity, where LDL particles can become smaller and cholesterol-depleted, meaning a normal-looking LDL cholesterol number can still accompany a high particle count. The research on this distinction is discussed in detail in the next section. For a deeper look at particle-based lipid markers, see this site’s guides to ApoB testing e la nostra Informativa apolipoprotein A1, the main protein carried by HDL particles.

Lifestyle and other ways to influence LDL cholesterol

Because LDL cholesterol responds to daily habits as well as genetics, lifestyle adjustments are usually the first step recommended for borderline or high results, alongside medication when risk is higher. Evidence-based approaches include the following.

• Replacing saturated and trans fats with unsaturated fats from sources like olive oil, nuts, and fatty fish
• Increasing soluble fiber intake from oats, beans, and fruit, which can help reduce cholesterol absorption in the gut
• Building in regular aerobic activity, such as brisk walking, most days of the week
• Reaching or maintaining a weight that is healthy for your body
• Quitting smoking, which can improve both LDL and HDL cholesterol over time
• Limiting alcohol intake, since heavy drinking can worsen overall lipid profiles

When lifestyle changes are not enough, or when cardiovascular risk is already high, clinicians may add cholesterol-lowering medications such as statins, ezetimibe, or newer injectable options. These decisions depend on individual risk calculations, not on the LDL number alone, which is why the same result can lead to different recommendations for two different people.

When to see a doctor about LDL cholesterol

Because high LDL cholesterol rarely causes symptoms on its own, most people find out about it through routine screening rather than because they feel unwell. The following situations are good reasons to schedule a conversation with a healthcare provider.

• A first lipid panel shows LDL cholesterol above 160 mg/dL, or above 190 mg/dL regardless of other factors
• A family history of early heart attack, stroke, or very high cholesterol, which can point toward familial hypercholesterolemia
• An existing diagnosis of heart disease, diabetes, or chronic kidney disease alongside a borderline or high LDL result
• Sudden chest pain, shortness of breath, or other symptoms that could indicate a cardiovascular event, which warrant emergency care rather than a routine appointment
• Uncertainty about how to interpret a lipid panel result or how often to repeat testing

Recent scientific advances

Lipid research has moved quickly over the past two to three years, and three developments are especially relevant to how LDL cholesterol results get interpreted today.

A large 2025 systematic review pooling data from 15 studies and more than 590,000 participants found that ApoB, the particle-counting marker described earlier in this article, more accurately reflected a person’s cardiovascular risk than LDL cholesterol in nearly every study analyzed. In simple terms, when LDL cholesterol and ApoB disagreed about how much risk a person carried, ApoB usually turned out to be the better predictor of later heart attacks and strokes. What this means for you: this does not make a standard LDL cholesterol test less useful for everyday screening, but it explains why a doctor might suggest an ApoB test as a follow-up, particularly if triglycerides are elevated or if someone has diabetes, since those are the situations where LDL cholesterol and particle count are most likely to tell different stories.

A related 2025 systematic review focused specifically on people with metabolic syndrome or type 2 diabetes and found a similar pattern: many of these individuals had LDL cholesterol readings that looked reassuring while their ApoB and non-HDL cholesterol, a marker combining LDL with other artery-clogging particles, remained elevated. What this means for you: if you live with diabetes or metabolic syndrome, a normal LDL cholesterol number is good news but may not be the full picture, and your clinician may want to look at additional lipid markers rather than relying on LDL cholesterol alone.

Separately, laboratory researchers have continued refining how LDL cholesterol itself gets calculated. Comparisons published in 2020 and again in 2025 confirmed that newer calculation formulas, including the Sampson and Martin-Hopkins equations, estimate LDL cholesterol more accurately than the older Friedewald formula once triglycerides rise above roughly 150 to 200 mg/dL. What this means for you: if your triglycerides are elevated, your lab may already be using one of these updated formulas, or your clinician may request a direct LDL measurement to avoid the small but meaningful errors that can occur with the older method at higher triglyceride levels.

Finally, a major national guideline update released in 2026 restored specific numeric LDL cholesterol treatment goals, replacing an older approach that focused only on percentage reductions. The updated guidance sets a target below 55 mg/dL for adults at very high cardiovascular risk being treated after a prior heart attack or stroke, and below 70 mg/dL for many people with established heart disease or strong risk factors. It also clarifies that ApoB testing is most useful as a next step once LDL cholesterol and related targets have already been met, especially for people with elevated triglycerides, diabetes, or LDL cholesterol that remains hard to lower. What this means for you: if you or a family member has known heart disease, expect these more specific numeric targets to come up in future appointments, and know that ApoB testing, if recommended, is meant to add detail rather than replace your LDL cholesterol result.

Glossario

Domande frequenti

What is a dangerously high LDL cholesterol level?

Most US guidance considers an LDL cholesterol level of 190 mg/dL or above to be very high, regardless of other risk factors, and it often prompts further testing for an inherited cause such as familial hypercholesterolemia. That said, “dangerous” depends on context. Someone with existing heart disease may be advised to treat a level as high as 100 mg/dL, while someone with no other risk factors may be monitored rather than treated at a similar number. A clinician can explain what a specific result means for your individual risk.

Can LDL cholesterol be lowered without medication?

For many people with mild to moderately elevated LDL cholesterol, diet changes, regular physical activity, weight management, and quitting smoking can meaningfully lower LDL cholesterol over a period of weeks to months. The degree of improvement varies by person and by how much of the elevation is driven by lifestyle versus genetics. People with very high levels or existing cardiovascular disease are more likely to need medication in addition to lifestyle changes to reach their target.

Does fasting affect an LDL cholesterol test?

Fasting for nine to twelve hours before a lipid panel is traditionally recommended, mainly because it improves the accuracy of the triglyceride measurement, which in turn affects the traditional LDL cholesterol calculation. Some laboratories and clinicians now accept non-fasting lipid panels for general screening, since research suggests the difference is often small for most people. Your healthcare provider or lab will tell you whether fasting is needed for your specific test.

Is LDL cholesterol the same in children as in adults?

Children can have their cholesterol checked, and pediatric guidelines use different reference ranges than adult guidelines, since normal levels shift somewhat with age and development. Universal screening is generally recommended once between ages nine and eleven, and again in early adulthood, with earlier or more frequent testing for children who have a family history of high cholesterol or early heart disease.

What is the difference between LDL cholesterol and VLDL cholesterol?

VLDL, or very low-density lipoprotein, is a related particle that mainly carries triglycerides rather than cholesterol, though it does contain some cholesterol and eventually converts into LDL in the bloodstream. VLDL cholesterol is not usually measured directly on a standard lipid panel but is instead estimated from the triglyceride level, which is part of why very high triglycerides can affect the accuracy of a calculated LDL cholesterol result.

How often should LDL cholesterol be tested?

Most healthy adults are advised to have a lipid panel, including LDL cholesterol, every four to six years starting around age twenty. People with risk factors such as diabetes, high blood pressure, smoking, obesity, or a family history of early heart disease are often tested more frequently, sometimes annually, and anyone already being treated for high cholesterol typically has it rechecked several months after starting or adjusting treatment.

Fonti

• Centers for Disease Control and Prevention — About Cholesterol — CDC, 2025 — link
• MedlinePlus, National Library of Medicine — Cholesterol — NIH/MedlinePlus, 2025 — link
• Mayo Clinic — High blood cholesterol: Diagnosis and treatment — Mayo Clinic, 2025 — link
• Sehayek D, Cole J, Bjornson E, et al. — ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk — Journal of Clinical Lipidology, 2025 — link
• Witt C, Renfroe LG, Lyons TS — Discordance between serum cholesterol concentration and atherogenic lipoprotein particle number in people with metabolic disease: A systematic review — Diabetes, Obesity and Metabolism, 2025 — link
• Sampson M, Ling C, Sun Q, et al. — A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia — JAMA Cardiology, 2020 — link
• American College of Cardiology / American Heart Association — 2026 Guideline on the Management of Dyslipidemia — Circulation, 2026 — link

Approfondimenti

• Test del colesterolo HDL: comprendere i risultati
• Test del colesterolo totale: una guida completa per interpretare i risultati
• Lipoproteina(a): comprendere questo marcatore del rischio cardiovascolare
• Advanced Lipid Panel: il tuo progetto per la resilienza del cuore e dello stress
• I migliori integratori per il colesterolo: benefici, rischi e guida

Scopri i tuoi referti con AI DiagMe

LDL cholesterol is just one piece of a broader cardiovascular picture that also includes HDL cholesterol, triglycerides, and increasingly ApoB. Seeing these results together, alongside markers like total cholesterol or lipoprotein(a), often makes it easier to understand what a lipid panel is really saying about your heart health. AI DiagMe helps you make sense of these numbers in plain language so you can have a more informed conversation with your doctor, without replacing the diagnosis or advice only a healthcare provider can give.

Ottieni l'interpretazione dei tuoi risultati in pochi minuti